Abstract is: The Lions Eye Institute (LEI) is an Australian medical research institute affiliated with the University of Western Australia. It was established in 1983 with support of the Lions Clubs of Western Australia and headquartered in the Perth suburb of Nedlands, Western Australia. The LEI is a not-for-profit centre of excellence that combines an ophthalmic clinic with scientific discovery developing techniques for the prevention of blindness and the reduction of pain from blinding eye conditions.
| research institute | Q31855 |
| nonprofit organization | Q163740 |
| P646 | Freebase ID | /m/06l1cy |
| P2427 | GRID ID | grid.1489.4 |
| P213 | ISNI | 0000000087378161 |
| P244 | Library of Congress authority ID | n91800806 |
| P6366 | Microsoft Academic ID | 104628220 |
| P856 | official website | https://www.lei.org.au/ |
| P10283 | OpenAlex ID | I104628220 |
| P3500 | Ringgold ID | 10111 |
| P6782 | ROR ID | 006vyay97 |
| P214 | VIAF ID | 126807306 |
| P7859 | WorldCat Identities ID (superseded) | lccn-n91800806 |
| P2002 | X username | LionsEyeInstAus |
| P1416 | affiliation | University of Western Australia | Q1517021 |
| P17 | country | Australia | Q408 |
| P101 | field of work | medical research | Q2752427 |
| P571 | inception | 1975-01-01 | |
| P2650 | interested in | eye disease | Q3041498 |
| P131 | located in the administrative territorial entity | Perth | Q3183 |
| Q43278903 | Allison M. McKendrick |
| Q57014130 | Andrew Mehnert |
| Q56361866 | Anna Oszmiana |
| Q38640380 | Annette K. Hoskin |
| Q61791245 | Anthony Kicic |
| Q39854851 | Antony Clark |
| Q61138272 | Carla Mellough |
| Q42242710 | Christopher E Andoniou |
| Q37373166 | Christopher J. Hammond |
| Q73400777 | D M Andrews |
| Q97088847 | Dan Zhang |
| Q100306512 | Danial Roshandel |
| Q43653925 | Danuta Bukowska |
| Q37373213 | David A. Mackey |
| Q91898890 | Jessica K Mountford |
| Q86634364 | Juanita Pappalardo |
| Q89888190 | Mark A Chia |
| Q96163098 | Mei-Ling Tay Kearney |
| Q89085897 | Rachael C Heath Jeffery |
| Q44645699 | Robert H. Eikelboom |
| Q37635014 | Seyhan Yazar |
| Q42698232 | Steven Adie |
| Q91099183 | Valentina Voigt |
| Q87660694 | Victoria P A Johnstone |
| Q73150505 | Xia Lou |
| Q64354180 | A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel |
| Q62815392 | A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia |
| Q66036160 | A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration |
| Q107214143 | A Study to Evaluate the Safety and Tolerability of EXN407 |
| Q63812054 | Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis |
| Q63228982 | Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel) |
| Q63338769 | Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema |
| Q65347114 | Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X) |
| Q63319604 | Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration |
| Q65346690 | Safety and Efficacy of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration |
| Q63401918 | Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) |
| Q65342070 | Study of of APL-2 Therapy in Patients Geographic Atrophy |
| Q64801528 | Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) |
| Q64635791 | Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema |
| Q102153453 | Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO | sponsor | P859 |
| Lions Eye Institute | wikipedia |
Search more.